Compare LNZA & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LNZA | MDAI |
|---|---|---|
| Founded | 2005 | 2013 |
| Country | United States | United States |
| Employees | 192 | 65 |
| Industry | Major Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.5M | 54.4M |
| IPO Year | N/A | N/A |
| Metric | LNZA | MDAI |
|---|---|---|
| Price | $5.73 | $1.72 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $14.00 | $3.00 |
| AVG Volume (30 Days) | 254.4K | ★ 277.7K |
| Earning Date | 05-18-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $55.80 | N/A |
| Revenue Next Year | N/A | $23.50 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.24 | $1.18 |
| 52 Week High | $44.00 | $2.97 |
| Indicator | LNZA | MDAI |
|---|---|---|
| Relative Strength Index (RSI) | 38.94 | 41.04 |
| Support Level | $5.22 | $1.48 |
| Resistance Level | $8.21 | $1.77 |
| Average True Range (ATR) | 0.82 | 0.09 |
| MACD | 0.30 | 0.01 |
| Stochastic Oscillator | 9.29 | 35.71 |
LanzaTech Global Inc is a provider of carbon management and conversion technologies, focused on transforming waste materials into high-value fuels, chemicals, and critical industrial inputs. Its mission is to drive energy resilience, industrial competitiveness, and supply chain security by leveraging scalable biotechnology solutions to maximize the value of domestic resources. The company operates in North America, Europe, the Middle East, Africa (EMEA), Asia, and Australia, with the majority of its revenue generated from North America.
Spectral AI Inc is an AI company focused on predictive medical diagnostics. Its DeepView System uses proprietary AI algorithms to distinguish between fully damaged, partially damaged and healthy human tissue characters invisible to the naked eye, at the initial time point of wound presentation. The DeepView System delivers a binary prediction on the wound's capacity to heal or not-heal by a specified time point in the future. The company focuses on the burn indication which is supported by the BARDA PBS contract.